Antoinette Cameron-Pimblett
Overview
Explore the profile of Antoinette Cameron-Pimblett including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
69
Followers
0
Related Specialty
Related Specialty
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
McGlacken-Byrne S, Suntharalingham J, Ishida M, Buonocore F, Del Valle I, Cameron-Pimblett A, et al.
J Clin Endocrinol Metab
. 2025 Feb;
PMID: 39999035
Context: Establishing the genetic basis of early-onset primary ovarian insufficiency (EO-POI, <25 years) is important, but defining variant pathogenicity is challenging. Objective: To elucidate the genetic architecture of EO-POI in...
2.
Cameron-Pimblett A, La Rosa C, Davies M, Suntharalingham J, Ishida M, Achermann J, et al.
J Clin Endocrinol Metab
. 2024 Jul;
PMID: 38961758
Context: Diabetes mellitus (DM) risk factors in Turner Syndrome (TS) may include autoimmunity, obesity, beta-cell dysfunction, genetic predisposition and insulin resistance (IR). Objective: Evaluate glucose tolerance and DM risk factors...
3.
Burt E, Davies M, Yasmin E, Cameron-Pimblett A, Talaulikar V, La Rosa C, et al.
Clin Endocrinol (Oxf)
. 2024 May;
101(1):51-59.
PMID: 38798185
Objective: Many women with Turner syndrome (TS) will consider fertility options and pregnancy. We wished to examine the fertility and pregnancy outcomes in women with TS undergoing oocyte donation (OD)...
4.
Suntharalingham J, Ishida M, Cameron-Pimblett A, McGlacken-Byrne S, Buonocore F, Del Valle I, et al.
Front Endocrinol (Lausanne)
. 2023 Oct;
14:1227164.
PMID: 37800145
Background: Women with Turner syndrome (TS) (45,X and related karyotypes) have an increased prevalence of conditions such as diabetes mellitus, obesity, hypothyroidism, autoimmunity, hypertension, and congenital cardiovascular anomalies (CCA). Whilst...
5.
Burt E, Ruff C, Yasmin E, Davies M, Cameron-Pimblett A, Butler G, et al.
Clin Endocrinol (Oxf)
. 2022 Aug;
98(1):68-73.
PMID: 35978390
Objective: Optimal breast development is an essential part of exogenous oestrogen treatment in females undergoing pubertal induction. We set out to develop a novel technique using three-dimensional (3D) imaging to...
6.
Burt E, Yasmin E, Davies M, Creighton S, Brain C, Ruff C, et al.
Clin Endocrinol (Oxf)
. 2022 Apr;
97(1):91-99.
PMID: 35436365
Objective: Induction of puberty with exogenous oestrogen results in considerable variability in final uterine and breast volumes. We set out to quantify the variability of these two outcome measures with...
7.
Attard C, Cameron-Pimblett A, Puri D, La Rosa C, Talaulikar V, Davies M, et al.
Clin Endocrinol (Oxf)
. 2020 Jun;
93(4):473-481.
PMID: 32579712
Objective: Age at first date and sexual intercourse have been observed to be delayed in women with Turner syndrome (TS), with delayed puberty being the main factor. We sought to...
8.
Attard C, Cameron-Pimblett A, Puri D, Elliot J, Wilson J, Talaulikar V, et al.
Clin Endocrinol (Oxf)
. 2019 Oct;
91(6):743-749.
PMID: 31612507
Objective: Women with early-onset oestrogen deficiency are at risk of reduced bone mineral density (BMD). We sought to assess fracture history and BMD in women with Turner syndrome (TS) and...
9.
Burt E, Davies M, Yasmin E, Cameron-Pimblett A, Mavrelos D, Talaulikar V, et al.
Clin Endocrinol (Oxf)
. 2019 Sep;
91(6):798-804.
PMID: 31487390
Objective: Adequate uterine growth is an essential component of pubertal induction with exogenous oestradiol in those with hypogonadism. Poor uterine development will render the individual vulnerable in the context of...
10.
A critical assessment of case reports describing absent uterus in subjects with oestrogen deficiency
Berglund A, Burt E, Cameron-Pimblett A, Davies M, Conway G
Clin Endocrinol (Oxf)
. 2019 Mar;
90(6):822-826.
PMID: 30820975
Objective: The dual diagnosis of hypoplastic uterus in association with ovarian dysgenesis is regularly reported but the pathogenesis of the association is unclear. The uterus, however, may be invisible to...